Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 39 min ago
PreprintCC BYmedRxiv

Pooled Multiplex Amplicon Massive Parallel Sequencing for High-Throughput Confirmation of Whole-Genome Sequencing Potentially Pathogenic Variants in Patients with Parkinsonism

  1. 1Institute of Medical Genetics, University Hospital and Faculty of Medicine and Dentistry, Palacky University 779 00 Olomouc, Czech Republic

Abstract

Whole-genome sequencing identifies large numbers of genetic variants, although only a subset requires independent confirmation for clinical interpretation. Sanger sequencing remains the standard confirmation method but is impractical for large-scale variant verification. We developed and evaluated a strategy for variant confirmation based on multi-amplicon massively parallel sequencing of pooled DNA samples. Whole-genome sequencing data were obtained from 86 individuals, including patients with parkinsonism and controls. Variants were selected using phenotype-driven filtering, ClinVar classification, and pathogenicity assessment criteria. A total of 307 variants were targeted using a custom amplicon panel comprising 290 amplicons. DNA samples were normalized, pooled into 16 mixtures, and sequenced following automated library preparation. Variant presence and sequencing quality were assessed using standard bioinformatic tools. Of the 307 selected variants, 243 were successfully confirmed. Unconfirmed variants included sequencing artifacts (18), insufficiently covered targets (5), large insertions or deletions exceeding 12 base pairs (36), and variants located within homopolymeric regions (5). Results for selected variants were concordant with Sanger sequencing, and observed variant frequencies corresponded to expected frequencies in pooled samples. This approach provides a robust, rapid, and cost-effective method for high-throughput genetic variants confirming identified by whole-genome sequencing while requiring only limited DNA input. Despite complete concordance with Sanger sequencing, larger validation studies are needed before multi-amplicon massively parallel sequencing can replace routine confirmatory testing.

Related

  1. Direct Amplification-Free Nanopore Sequencing of Leishmania from Cutaneous Biopsies
    F. Alkhaldi, A. S. Al Rashed, C. Frokjaer-Jensen
    medRxivPreprintAll rights reservedFull textInfectious diseasemedRxiv
  2. Integrated Analysis of Serotonin-Related Biomarkers in Thoracic Aortic Aneurysm Based on Machine Learning and Single-Cell Sequencing Data
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. From Rescue Therapy to Mechanism-Based Sequencing in Refractory Myasthenia Gravis: A Narrative Review with an Illustrative Clinical Case
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Rapid whole-genome sequencing in the pediatric intensive care unit: from etiologic diagnosis to precision management—a narrative review
    Xin Yang, Di Liu
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Analysis and validation of prognostic markers for thyroid cancer by single-cell and bulk RNA sequencing
    Yang Yang, Liufei Yang, Xianfeng Jiang
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@misc{vrtel2026pooled,
  title = {{Pooled Multiplex Amplicon Massive Parallel Sequencing for High-Throughput Confirmation of Whole-Genome Sequencing Potentially Pathogenic Variants in Patients with Parkinsonism}},
  author = {R. Vrtel and R. Vodicka and K. Kolarikova and M. S. Vodickova and K. Mensikova and P. Kanovsky and M. Kolarikova and B. Majerova and M. Prochazka},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.10.26367697},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.10.26367697v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Pooled Multiplex Amplicon Massive Parallel Sequencing for High-Throughput Confirmation of Whole-Genome Sequencing Potentially Pathogenic Variants in Patients with Parkinsonism
AU  - R. Vrtel
AU  - R. Vodicka
AU  - K. Kolarikova
AU  - M. S. Vodickova
AU  - K. Mensikova
AU  - P. Kanovsky
AU  - M. Kolarikova
AU  - B. Majerova
AU  - M. Prochazka
PY  - 2026
DA  - 2026/11/10
PB  - medRxiv
DO  - 10.64898/2026.11.10.26367697
UR  - https://www.medrxiv.org/content/10.64898/2026.11.10.26367697v1
AB  - Whole-genome sequencing identifies large numbers of genetic variants, although only a subset requires independent confirmation for clinical interpretation. Sanger sequencing remains the standard confirmation method but is impractical for large-scale variant verification. We developed and evaluated a strategy for variant confirmation based on multi-amplicon massively parallel sequencing of pooled DNA samples. Whole-genome sequencing data were obtained from 86 individuals, including patients with parkinsonism and controls. Variants were selected using phenotype-driven filtering, ClinVar classification, and pathogenicity assessment criteria. A total of 307 variants were targeted using a custom amplicon panel comprising 290 amplicons. DNA samples were normalized, pooled into 16 mixtures, and sequenced following automated library preparation. Variant presence and sequencing quality were assessed using standard bioinformatic tools. Of the 307 selected variants, 243 were successfully confirmed. Unconfirmed variants included sequencing artifacts (18), insufficiently covered targets (5), large insertions or deletions exceeding 12 base pairs (36), and variants located within homopolymeric regions (5). Results for selected variants were concordant with Sanger sequencing, and observed variant frequencies corresponded to expected frequencies in pooled samples. This approach provides a robust, rapid, and cost-effective method for high-throughput genetic variants confirming identified by whole-genome sequencing while requiring only limited DNA input. Despite complete concordance with Sanger sequencing, larger validation studies are needed before multi-amplicon massively parallel sequencing can replace routine confirmatory testing.
ER  -